Alexion Shareholders Approve Acquisition by AstraZeneca
10:01 AM EDT, 05/11/2021 (MT Newswires) -- Alexion Pharmaceuticals (ALXN) said Tuesday its shareholders have voted to approve the company's acquisition by AstraZeneca (AZN).
In December 2020, the Boston-based biopharmaceutical company agreed to be acquired by the British drugmaker in a cash-and-stock deal worth $39 billion.
The deal is expected to close in Q3, subject to regulatory clearances.
Shares were marginally lower in morning session.
Price: 170.86, Change: -0.95, Percent Change: -0.55